Cargando…

Fecal microbiota transplantation in non-communicable diseases: Recent advances and protocols

Fecal microbiota transplant (FMT) is a therapeutic method that aims to restore normal gut microbial composition in recipients. Currently, FMT is approved in the USA to treat recurrent and refractory Clostridioides difficile infection and has been shown to have great efficacy. As such, significant re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hamamah, Sevag, Gheorghita, Roxana, Lobiuc, Andrei, Sirbu, Ioan-Ovidiu, Covasa, Mihai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9773399/ https://www.ncbi.nlm.nih.gov/pubmed/36569149 http://dx.doi.org/10.3389/fmed.2022.1060581

Ejemplares similares

The Use of Biopolymers as a Natural Matrix for Incorporation of Essential Oils of Medicinal Plants
por: Gheorghita Puscaselu, Roxana, et al.
Publicado: (2022)

Impact of Nutrition, Microbiota Transplant and Weight Loss Surgery on Dopaminergic Alterations in Parkinson’s Disease and Obesity
por: Hamamah, Sevag, et al.
Publicado: (2022)

Gut Microbiota Restores Central Neuropeptide Deficits in Germ-Free Mice
por: Hamamah, Sevag, et al.
Publicado: (2022)

Alginate: From Food Industry to Biomedical Applications and Management of Metabolic Disorders
por: Gheorghita Puscaselu, Roxana, et al.
Publicado: (2020)

Treatment of Dyslipidemia through Targeted Therapy of Gut Microbiota
por: Flaig, Brandon, et al.
Publicado: (2023)

Introduction and Characteristics of SARS-CoV-2 in North-East of Romania During the First COVID-19 Outbreak
por: Lobiuc, Andrei, et al.
Publicado: (2021)

Role of Microbiota-Gut-Brain Axis in Regulating Dopaminergic Signaling
por: Hamamah, Sevag, et al.
Publicado: (2022)

Reduced Striatal Dopamine Transporter Availability and Heightened Response to Natural and Pharmacological Stimulation in CCK-1R-Deficient Obese Rats
por: Hamamah, Sevag, et al.
Publicado: (2023)

Dietary Fat Modulation of Gut Microbiota and Impact on Regulatory Pathways Controlling Food Intake
por: Hamamah, Sevag, et al.
Publicado: (2023)

Emergence of the First Strains of SARS-CoV-2 Lineage B.1.1.7 in Romania: Genomic Analysis
por: Lobiuc, Andrei, et al.
Publicado: (2021)

Authors’ Response to Peer Reviews of “Emergence of the First Strains of SARS-CoV-2 Lineage B.1.1.7 in Romania: Genomic Analysis”
por: Lobiuc, Andrei, et al.
Publicado: (2021)

Detection of Biological Molecules Using Nanopore Sensing Techniques
por: Șoldănescu, Iuliana, et al.
Publicado: (2023)

A Conservative Replacement in the Transmembrane Domain of SARS-CoV-2 ORF7a as a Putative Risk Factor in COVID-19
por: Lobiuc, Andrei, et al.
Publicado: (2021)

The Future Packaging of the Food Industry: The Development and Characterization of Innovative Biobased Materials with Essential Oils Added
por: Puscaselu, Roxana Gheorghita, et al.
Publicado: (2022)

Applications of Biopolymers for Drugs and Probiotics Delivery
por: Gheorghita, Roxana, et al.
Publicado: (2021)

Microbiota Transplant in the Treatment of Obesity and Diabetes: Current and Future Perspectives
por: Napolitano, Michael, et al.
Publicado: (2020)

Fecal Microbiota and Human Intestinal Fluid Transplantation: Methodologies and Outlook
por: Chen, Ye, et al.
Publicado: (2022)

Hot topics on fecal microbiota transplantation for the treatment of inflammatory bowel disease
por: Zhang, Xiaochen, et al.
Publicado: (2022)

Fecal Microbiota Transplantation as a Tool for Therapeutic Modulation of Non-gastrointestinal Disorders
por: Liptak, Robert, et al.
Publicado: (2021)

Intestinal Sensing by Gut Microbiota: Targeting Gut Peptides
por: Covasa, Mihai, et al.
Publicado: (2019)

A Randomized Placebo-Controlled Trial of Combination Therapy With Post-triple-antibiotic-therapy Fecal Microbiota Transplantation and Alginate for Ulcerative Colitis: Protocol
por: Ishikawa, Dai, et al.
Publicado: (2022)

From fecal microbiota transplantation toward next-generation beneficial microbes: The case of Anaerobutyricum soehngenii
por: Wortelboer, Koen, et al.
Publicado: (2022)

Fecal microbiota transplantation in irritable bowel syndrome: A meta-analysis of randomized controlled trials
por: Samuthpongtorn, Chatpol, et al.
Publicado: (2022)

Fecal Microbiota Transplant in Recurrent Clostridium Difficile Infections: A Systematic Review
por: Gupta, Kunal, et al.
Publicado: (2022)

Fecal Microbiota Transplantation Role in the Treatment of Alzheimer's Disease: A Systematic Review
por: Nassar, Sondos T, et al.
Publicado: (2022)

The Efficacy and Safety of Fecal Microbiota Transplantation Combined With Biofeedback for Mixed Constipation: A Retrospective Cohort Study
por: Yang, Bo, et al.
Publicado: (2021)

How to Initiate Fecal Microbiota Transplantation in Developing Countries Using the Behavior Economics Concept of “Choice Architecture”
por: Savigamin, Chatuthanai, et al.
Publicado: (2022)

Fecal microbiota transplantation in patients with post-infectious irritable bowel syndrome: A randomized, clinical trial
por: Tkach, Sergii, et al.
Publicado: (2022)

Fecal Microbiota Transplantation in Recurrent Clostridium Difficile Infection: Is it Superior to Other Conventional Methods?
por: Lin, Zayar, et al.
Publicado: (2020)

Intestinal Dysbiosis Disguised as a Rectal Fistula Treated With Autologous Fecal Microbiota Transplantation
por: Scibelli, Nicolina, et al.
Publicado: (2021)

Treating From the Inside Out: Relevance of Fecal Microbiota Transplantation to Counteract Gut Damage in GVHD and HIV Infection
por: Ouyang, Jing, et al.
Publicado: (2020)

Features of Gut Microbiome Associated With Responses to Fecal Microbiota Transplantation for Inflammatory Bowel Disease: A Systematic Review
por: Zhang, Jindong, et al.
Publicado: (2022)

Fecal microbiota transplantation for treatment of refractory or recurrent Clostridioides difficile infection in Taiwan: a cost-effectiveness analysis
por: Lan, Kai-Yen, et al.
Publicado: (2023)

Fecal Microbiota Transplantation: Is It Safe?
por: Park, Seon-Young, et al.
Publicado: (2021)

Long-Term Follow-Up Results of Fecal Microbiota Transplantation for Irritable Bowel Syndrome: A Single-Center, Retrospective Study
por: Cui, Jiaqu, et al.
Publicado: (2021)

The biodiversity dose-response curve translates theory and practice from ecological restoration into research and clinical priorities for fecal microbiota transplantation
por: Orr, Matthew R.
Publicado: (2022)

Future Antimicrobials: Natural and Functionalized Phenolics
por: Lobiuc, Andrei, et al.
Publicado: (2023)

Fecal microbiota transplantation: the state of the art
por: Di Bella, Stefano, et al.
Publicado: (2013)

Fecal Microbiota Transplant: Benefits and Risks
por: Weil, Ana A., et al.
Publicado: (2015)

Clinical Usefulness of Fecal Microbiota Transplantation
por: Park, Jung Ho
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_uikisv6a1j5mrs0i9jtkc4pu2e